Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic(University of Copenhagen), Richard Pratley(Translational Research Institute for Metabolism and Diabetes), Johannes F.E. Mann(Katholische Stiftungshochschule München), Katherine R. Tuttle(Providence Regional Medical Center Everett), Nanna L. Lausvig(University of Copenhagen), Heidrun Bosch‐Traberg(University of Copenhagen), Peter Rossing(Steno Diabetes Centers), Florian M.M. Baeres(University of Copenhagen), George L. Bakris(Pennsylvania State System of Higher Education), Thomas Idorn(University of Copenhagen), Kenneth W. Mahaffey(Cardiovascular Institute of the South)
Cited by 1,481
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k